- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04044924
Geriatric Head Trauma Short Term Outcomes Project (GREAT-STOP)
July 31, 2022 updated by: Florida Atlantic University
This prospective observational study will examine the incidence of intracranial hemorrhage.
The investigators will compare patients on anticoagulant and/or antiplatelet therapy with head trauma compared to patients not on these medications.
While many studies have sought to quantify the incidence of intracranial hemorrhage in these patients, there is considerable controversy regarding their care and what to do after an initial negative head CT in anticoagulated geriatric patients who have experienced head trauma.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
5387
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Delray Beach, Florida, United States, 33484
- Delray Medical Center
-
West Palm Beach, Florida, United States, 33407
- St. Mary's Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The Delray Medical Center and St. Mary's Medical Center emergency departments will be the major focal points for the study.
These medical centers are located in Palm Beach County, Florida.
Florida has the highest percentage of geriatric patients in the United States and, in particular, Palm Beach County has over 250,000 residents over the age of 65.
Description
Inclusion Criteria: Patients seen in the emergency department for head trauma
Exclusion Criteria: Penetrating head trauma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants with 14 Day ED Returns
Time Frame: 14 days
|
Return visit to ED within 2 weeks
|
14 days
|
Number of Participants with Primary Intracranial Hemorrhage
Time Frame: initial hospital visit
|
ICH on initial head CT scan
|
initial hospital visit
|
Number of Participants with Delayed Intracranial Hemorrhage
Time Frame: 14 days
|
ICH on repeat CT scan
|
14 days
|
Number of Participants with Hospitalizations at 14 days
Time Frame: 14 days
|
If patient is admitted for any reason after initial ED visit
|
14 days
|
Mortality of Participants
Time Frame: 60 days
|
Death of patient from any cause at primary visit or up to 60 days from follow-up
|
60 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
New Symptoms
Time Frame: 60 days
|
Any new symptoms
|
60 days
|
Life alterations
Time Frame: 60 days
|
Descriptive information from telephone interviews about how patients changed activities after head trauma
|
60 days
|
New interventions since fall
Time Frame: 60 days
|
Additional therapies or intervention instituted after minor head trauma
|
60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Richard Shih, MD, Florida Atlantic University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 15, 2019
Primary Completion (Actual)
November 14, 2020
Study Completion (Actual)
November 14, 2020
Study Registration Dates
First Submitted
August 1, 2019
First Submitted That Met QC Criteria
August 1, 2019
First Posted (Actual)
August 5, 2019
Study Record Updates
Last Update Posted (Actual)
August 3, 2022
Last Update Submitted That Met QC Criteria
July 31, 2022
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1326154
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fall
-
University of AmsterdamCompletedDeprescribing | Fall | Fall Injury | Fall Patients | Accidental FallNetherlands
-
University of Illinois at Urbana-ChampaignUnknownFall Injury | Fall Prevention | Fall Safety
-
University of ArizonaVirginia Polytechnic Institute and State UniversityNot yet recruiting
-
Neuroscience Research AustraliaThe University of New South WalesCompleted
-
Aalborg University HospitalCompleted
-
Leon BrüllHumboldt-Universität zu BerlinTerminatedFall Risk, Fall PreventionGermany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...VU University of AmsterdamNot yet recruitingFall | Aged | Fall Injury | Fall Patients | Polypharmacy | Accidental Fall | Aged, 80 and Over | DeprescriptionsNetherlands
-
Dalarna UniversitySormland County Council, SwedenRecruiting
-
University of PotsdamSwiss Council for Accident Prevention; Prof. Dr. Reto W. Kressig and Dr. Yves...CompletedFall Prevention | Fall Risk FactorsGermany
-
MedicusTek, IncCompletedPatient Fall | Accidental Fall From BedTaiwan